Literature DB >> 12147591

Injured corneal epithelial cells promote myodifferentiation of corneal fibroblasts.

Kunihiko Nakamura1, Daijiro Kurosaka, Mami Yoshino, Takeshi Oshima, Hiroyo Kurosaka.   

Abstract

PURPOSE: To determine whether injured corneal epithelial cells stimulate myodifferentiation in corneal fibroblasts and whether transforming growth factor (TGF)-beta is involved.
METHODS: Rabbit corneal fibroblasts were cultured on collagen gel, with or without cocultured corneal epithelial cells or with partially scraped epithelial cells, on a companion plate separated by a permeable membrane. To evaluate fibroblast-induced gel contraction, gel thickness was measured daily relative to the original thickness. Total fibroblasts on the gel were counted. Myofibroblasts were counted by using immunocytochemical identification with anti-alpha-smooth muscle actin (alpha-SMA). TGF-beta was assayed in the media on days 3 and 6. These procedures also were performed in the presence of anti-TGF-beta antibody.
RESULTS: Gel contraction, alpha-SMA-positive cells, and total cell number were significantly greater on gels with injured epithelial cells than on gels without epithelial cells or with uninjured epithelial cells, as was TGF-beta concentration in the media. Anti-TGF-beta antibody eliminated these differences.
CONCLUSIONS: Injured epithelial cells stimulate myodifferentiation in fibroblasts through one or more soluble factors, including TGF-beta.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12147591

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  19 in total

Review 1.  Corneal wound healing.

Authors:  Steven E Wilson
Journal:  Exp Eye Res       Date:  2020-06-15       Impact factor: 3.467

2.  Mutual paracrine effects of colorectal tumour cells and stromal cells: modulation of tumour and stromal cell differentiation and extracellular matrix component production in culture.

Authors:  Sydney Mukaratirwa; Jos F Koninkx; Erik Gruys; Hubertus Nederbragt
Journal:  Int J Exp Pathol       Date:  2005-08       Impact factor: 1.925

3.  Clinical analysis of risk factors contributing to recurrence of pterygium after excision and graft surgery.

Authors:  Sang Won Ha; Joon Ho Park; Im Hee Shin; Hong Kyun Kim
Journal:  Int J Ophthalmol       Date:  2015-06-18       Impact factor: 1.779

4.  Matrix Metalloproteinase-14 as an Instigator of Fibrosis in Human Pterygium and Its Pharmacological Intervention.

Authors:  Cesar Masitas; Zhihong Peng; Man Wang; Mohini Mohan Konai; Luis F Avila-Cobian; Leslie Lemieux; John Hovanesian; James E Grady; Shahriar Mobashery; Mayland Chang
Journal:  ACS Pharmacol Transl Sci       Date:  2022-07-19

5.  Optical effects of anti-TGFbeta treatment after photorefractive keratectomy in a cat model.

Authors:  Jens Bühren; Lana Nagy; Jennifer N Swanton; Shawn Kenner; Scott MacRae; Richard P Phipps; Krystel R Huxlin
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-10-24       Impact factor: 4.799

6.  Human adenovirus type 37 and the BALB/c mouse: progress toward a restricted adenovirus keratitis model (an American Ophthalmological Society thesis).

Authors:  James Chodosh
Journal:  Trans Am Ophthalmol Soc       Date:  2006

7.  Corneal stromal cell plasticity: in vitro regulation of cell phenotype through cell-cell interactions in a three-dimensional model.

Authors:  Samantha L Wilson; Ying Yang; Alicia J El Haj
Journal:  Tissue Eng Part A       Date:  2013-09-09       Impact factor: 3.845

8.  Laminins in normal, keratoconus, bullous keratopathy and scarred human corneas.

Authors:  Berit Byström; Ismo Virtanen; Patricia Rousselle; Kaoru Miyazaki; Christina Lindén; Fatima Pedrosa Domellöf
Journal:  Histochem Cell Biol       Date:  2007-05-11       Impact factor: 2.531

9.  Effect of different treatment regimen with dexamethasone and acetylcysteine on corneal wound healing in rabbits.

Authors:  Ali Asghar Sarchahi; Abdolhamid Meimandi Parizi; Masoomeh Eghtedari; Salar Keshavarz
Journal:  Iran J Med Sci       Date:  2011-09

10.  Topical rosiglitazone is an effective anti-scarring agent in the cornea.

Authors:  Krystel R Huxlin; Holly B Hindman; Kye-Im Jeon; Jens Bühren; Scott MacRae; Margaret DeMagistris; David Ciufo; Patricia J Sime; Richard P Phipps
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.